$XNCR
Xencor Inc Stock $xncr

$xncr Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000132673224000043 Filed on August 05, 2024

Income Statement

Concept	2024 Q3	2024 Q2
Revenue	$10.70M	$17.00M
YoY Change	-81.93%	-62.66%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$14.77M	$17.75M
YoY Change	18.14%	54.85%
% of Gross Profit
Research & Development	$58.23M	$61.53M
YoY Change	-10.34%	2.45%
% of Gross Profit
Depreciation & Amortization	$3.054M	$3.024M
YoY Change	-4.56%	4.82%
% of Gross Profit
Operating Expenses	$72.99M	$79.28M
YoY Change	-5.73%	10.85%
Operating Profit	-$62.28M	-$62.32M
YoY Change	240.94%	139.71%
Interest Expense	$15.90M	-$3.890M
YoY Change	-364.93%	-196.0%
% of Operating Profit
Other Income/Expense, Net	$15.99M	-$4.974M
YoY Change	-366.39%	55166.67%
Pretax Income	-$46.30M	-$67.29M
YoY Change	90.77%	206.51%
Income Tax	$0.00	$100.0K
% Of Pretax Income
Net Earnings	-$45.14M	-$65.96M
YoY Change	86.01%	200.46%
Net Earnings / Revenue	-421.9%	-388.02%
Basic Earnings Per Share	-$0.71	-$1.07
Diluted Earnings Per Share	-$0.71	-$1.07
COMMON SHARES
Basic Shares Outstanding	61.83M shares	61.66M shares
Diluted Shares Outstanding	64.02M shares	61.68M shares

Balance Sheet

Concept	2024 Q3	2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$543.0M	$508.4M
YoY Change	9.8%	-7.79%
Cash & Equivalents	$29.03M	$30.77M
Short-Term Investments	$513.9M	$477.6M
Other Short-Term Assets	$20.15M	$23.99M
YoY Change	-6.73%	8.19%
Inventory
Prepaid Expenses
Receivables	$10.21M	$22.07M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$573.3M	$554.5M
YoY Change	0.38%	-6.59%
LONG-TERM ASSETS
Property, Plant & Equipment	$62.40M	$63.87M
YoY Change	-8.28%	-36.79%
Goodwill
YoY Change
Intangibles	$17.92M	$18.78M
YoY Change	-4.4%	0.37%
Long-Term Investments	$290.3M	$148.6M
YoY Change	243.11%	131.49%
Other Assets	$498.0K	$498.0K
YoY Change	-24.55%	-16.72%
Total Long-Term Assets	$410.3M	$271.7M
YoY Change	97.97%	47.21%
TOTAL ASSETS
Total Short-Term Assets	$573.3M	$554.5M
Total Long-Term Assets	$410.3M	$271.7M
Total Assets	$983.6M	$826.2M
YoY Change	26.36%	6.17%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$18.77M	$15.84M
YoY Change	25.41%	12.35%
Accrued Expenses	$25.41M	$19.56M
YoY Change	3.82%	-13.72%
Deferred Revenue	$0.00	$0.00
YoY Change	-100.0%	-100.0%
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$7.749M	$6.947M
YoY Change
Total Short-Term Liabilities	$91.97M	$80.08M
YoY Change	73.4%	79.42%
LONG-TERM LIABILITIES
Long-Term Debt	$10.17M	$12.31M
YoY Change
Other Long-Term Liabilities	$160.6M	$171.2M
YoY Change	184.74%	213.53%
Total Long-Term Liabilities	$10.17M	$12.31M
YoY Change	-81.97%	-77.45%
TOTAL LIABILITIES
Total Short-Term Liabilities	$91.97M	$80.08M
Total Long-Term Liabilities	$10.17M	$12.31M
Total Liabilities	$262.7M	$263.6M
YoY Change	140.12%	165.63%
SHAREHOLDERS EQUITY
Retained Earnings	-$643.5M	-$598.4M
YoY Change	44.52%	42.13%
Common Stock	$701.0K	$619.0K
YoY Change	15.49%	1.98%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$723.8M	$564.3M
YoY Change
Total Liabilities & Shareholders Equity	$983.6M	$826.2M
YoY Change	26.36%	6.17%

Cashflow Statement

Concept	2024 Q3	2024 Q2
OPERATING ACTIVITIES
Net Income	-$45.14M	-$65.96M
YoY Change	86.01%	200.46%
Depreciation, Depletion And Amortization	$3.054M	$3.024M
YoY Change	-4.56%	4.82%
Cash From Operating Activities	-$26.02M	-$65.34M
YoY Change	-4.7%	71.04%
INVESTING ACTIVITIES
Capital Expenditures	$2.122M	$3.646M
YoY Change	-37.59%	-26.13%
Acquisitions
YoY Change
Other Investing Activities	-$161.3M	$69.66M
YoY Change	-431.29%	1872.87%
Cash From Investing Activities	-$163.5M	$66.02M
YoY Change	-460.04%	-4798.65%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	187.7M	-943.0K
YoY Change	46835.0%	-149.09%
NET CHANGE
Cash From Operating Activities	-26.02M	-65.34M
Cash From Investing Activities	-163.5M	66.02M
Cash From Financing Activities	187.7M	-943.0K
Net Change In Cash	-1.736M	-264.0K
YoY Change	-109.38%	-99.3%
FREE CASH FLOW
Cash From Operating Activities	-$26.02M	-$65.34M
Capital Expenditures	$2.122M	$3.646M
Free Cash Flow	-$28.14M	-$68.98M
YoY Change	-8.34%	59.92%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	59922784	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	59922784	shares
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	727496000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	924000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-57436000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	12599000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	683583000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	677000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	1242000	usd
CY2023Q2	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-20189000	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	13563000	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	678876000	usd
	us-gaap	Profit Loss ProfitLoss	-136117000	usd
	us-gaap	Profit Loss ProfitLoss	-82717000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	6059000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	5130000	usd
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	10037000	usd
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	4345000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	28611000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	26162000	usd
	xncr	Noncash Consideration Received From Revenue Contracts NoncashConsiderationReceivedFromRevenueContracts	0	usd
	xncr	Noncash Consideration Received From Revenue Contracts NoncashConsiderationReceivedFromRevenueContracts	10000000	usd
	us-gaap	Noncash Project Abandonment Costs NoncashProjectAbandonmentCosts	784000	usd
	us-gaap	Noncash Project Abandonment Costs NoncashProjectAbandonmentCosts	594000	usd
	us-gaap	Debt Securities Available For Sale Gain Loss DebtSecuritiesAvailableForSaleGainLoss	3000	usd
	us-gaap	Debt Securities Available For Sale Gain Loss DebtSecuritiesAvailableForSaleGainLoss	0	usd
	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	-9702000	usd
	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	-2610000	usd
	us-gaap	Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount	20430000	usd
	us-gaap	Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount	0	usd
	us-gaap	Paid In Kind Interest PaidInKindInterest	1900000	usd
	us-gaap	Paid In Kind Interest PaidInKindInterest	0	usd
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-6000	usd
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-1379000	usd
	xncr	Increase Decrease In Accounts And Other Receivables And Contract With Customer Assets IncreaseDecreaseInAccountsAndOtherReceivablesAndContractWithCustomerAssets	10783000	usd
	xncr	Increase Decrease In Accounts And Other Receivables And Contract With Customer Assets IncreaseDecreaseInAccountsAndOtherReceivablesAndContractWithCustomerAssets	-8978000	usd
	us-gaap	Increase Decrease In Accrued Investment Income Receivable IncreaseDecreaseInAccruedInvestmentIncomeReceivable	1705000	usd
	us-gaap	Increase Decrease In Accrued Investment Income Receivable IncreaseDecreaseInAccruedInvestmentIncomeReceivable	-420000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	5691000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1127000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1924000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	4009000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-4007000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-288000	usd
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-5782000	usd
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	0	usd
	xncr	Increase Decrease In Lease Liabilities And Right Of Use Assets IncreaseDecreaseInLeaseLiabilitiesAndRightOfUseAssets	426000	usd
	xncr	Increase Decrease In Lease Liabilities And Right Of Use Assets IncreaseDecreaseInLeaseLiabilitiesAndRightOfUseAssets	582000	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	0	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-22455000	usd
	us-gaap	Increase Decrease In Loans Deferred Income IncreaseDecreaseInLoansDeferredIncome	16312000	usd
	us-gaap	Increase Decrease In Loans Deferred Income IncreaseDecreaseInLoansDeferredIncome	0	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-120595000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-68814000	usd
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	259130000	usd
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	276715000	usd
	us-gaap	Proceeds From Sale Of Equity Securities Fv Ni ProceedsFromSaleOfEquitySecuritiesFvNi	4236000	usd
	us-gaap	Proceeds From Sale Of Equity Securities Fv Ni ProceedsFromSaleOfEquitySecuritiesFvNi	0	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	1549000	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	1490000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3158000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	14636000	usd
	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	347966000	usd
	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	339580000	usd
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	9969000	usd
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	0	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	98334000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	46739000	usd
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	1927000	usd
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	1601000	usd
	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	930000	usd
	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	1242000	usd
	xncr	Advance Future Royalty And Milestone Payments AdvanceFutureRoyaltyAndMilestonePayments	3614000	usd
	xncr	Advance Future Royalty And Milestone Payments AdvanceFutureRoyaltyAndMilestonePayments	0	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-757000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2843000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-23018000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-19232000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	54170000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	53942000	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	31152000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	34710000	usd
	us-gaap	Interest Paid Net InterestPaidNet	21000	usd
	us-gaap	Interest Paid Net InterestPaidNet	14000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	6100000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
	us-gaap	Debt Securities Available For Sale Unrealized Gain Loss DebtSecuritiesAvailableForSaleUnrealizedGainLoss	-1942000	usd
	us-gaap	Debt Securities Available For Sale Unrealized Gain Loss DebtSecuritiesAvailableForSaleUnrealizedGainLoss	5093000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	7166000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	30768000	usd
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	34710000	usd
CY2024Q2	us-gaap	Restricted Cash RestrictedCash	384000	usd
CY2023Q2	us-gaap	Restricted Cash RestrictedCash	0	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	31152000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	34710000	usd
	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated interim financial statements in conformity with GAAP requires management to make certain estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, other comprehensive income (loss) and the related disclosures. On an ongoing basis, management evaluates its estimates, including estimates related to its accrued clinical trial and manufacturing development expenses, stock-based compensation expense, evaluation of intangible assets, investments, leases and other assets for evidence of impairment, fair value measurements, and contingencies. Significant estimates in these consolidated interim financial statements include estimates made for royalty revenue, accrued research and development expenses, stock-based compensation expenses, intangible assets, incremental borrowing rate for right-of-use asset and lease liability, estimated standalone selling price of performance obligations, estimated time for completing delivery of performance obligations under certain arrangements, the likelihood of recognizing variable consideration, the carrying value of equity instruments without a readily determinable fair value, and recoverability of deferred tax assets.</span></div>
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reclassifications</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain prior year amounts in the consolidated financial statements and the notes thereto have been reclassified to conform to the current period's presentation. These reclassifications did not affect the prior period's total assets, liabilities, stockholders' equity, net loss or cash flows. During the six months ended June 30, 2024, we adopted a change in </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">presentation on our consolidated statements of loss to include loss from disposal of fixed assets in operating expenses. The prior period has been revised to reflect this change in the presentation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">.</span></div>
CY2024Q2	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0	usd
CY2023Q2	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0	usd
	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0	usd
	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0	usd
	xncr	Marketable Securities Impairment Losses And Recoveries MarketableSecuritiesImpairmentLossesAndRecoveries	0	usd
	xncr	Marketable Securities Impairment Losses And Recoveries MarketableSecuritiesImpairmentLossesAndRecoveries	0	usd
CY2023Q2	xncr	Marketable Securities Impairment Losses And Recoveries MarketableSecuritiesImpairmentLossesAndRecoveries	0	usd
CY2024Q2	xncr	Marketable Securities Impairment Losses And Recoveries MarketableSecuritiesImpairmentLossesAndRecoveries	0	usd
CY2024Q2	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	-500000	usd
	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	-1900000	usd
CY2023Q2	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	1800000	usd
	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	5100000	usd
	us-gaap	Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount	20400000	usd
	us-gaap	Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount	0	usd
CY2023Q2	us-gaap	Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount	0	usd
CY2024Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-65963000	usd
CY2023Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-21954000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-133996000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-82717000	usd
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	61676444	shares
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	61676444	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	59807558	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	59807558	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	61444384	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	61444384	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	59922784	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	59922784	shares
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.07
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.07
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.37
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.37
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.18
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.18
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.38
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.38
CY2024Q2	xncr	Cash And Cash Equivalents And Marketable Securities Amortized Cost CashAndCashEquivalentsAndMarketableSecuritiesAmortizedCost	566499000	usd
CY2024Q2	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	12000	usd
CY2024Q2	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	653000	usd
CY2024Q2	us-gaap	Investments Investments	565858000	usd
CY2024Q2	us-gaap	Investments Investments	565858000	usd
CY2023Q4	xncr	Cash And Cash Equivalents And Marketable Securities Amortized Cost CashAndCashEquivalentsAndMarketableSecuritiesAmortizedCost	667455000	usd
CY2023Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	1379000	usd
CY2023Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	77000	usd
CY2023Q4	us-gaap	Investments Investments	668757000	usd
CY2023Q4	us-gaap	Investments Investments	668757000	usd
CY2024Q2	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	449715000	usd
CY2024Q2	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	449372000	usd
CY2024Q2	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	105160000	usd
CY2024Q2	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	104862000	usd
CY2024Q2	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	554875000	usd
CY2024Q2	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	554234000	usd
CY2024Q2	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	365198000	usd
CY2024Q2	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	349000	usd
CY2024Q2	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	91373000	usd
CY2024Q2	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	304000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	74619000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	77000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	0	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	0	usd
CY2024Q2	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	-12000000.0	usd
	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	-9700000	usd
CY2023Q2	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	300000	usd
	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	-2600000	usd
CY2024Q2	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	-12027000	usd
CY2023Q2	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	288000	usd
	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	-9702000	usd
	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	-2610000	usd
CY2024Q2	us-gaap	Equity Securities Fv Ni Realized Gain Loss EquitySecuritiesFvNiRealizedGainLoss	-2012000	usd
CY2023Q2	us-gaap	Equity Securities Fv Ni Realized Gain Loss EquitySecuritiesFvNiRealizedGainLoss	0	usd
	us-gaap	Equity Securities Fv Ni Realized Gain Loss EquitySecuritiesFvNiRealizedGainLoss	827000	usd
	us-gaap	Equity Securities Fv Ni Realized Gain Loss EquitySecuritiesFvNiRealizedGainLoss	0	usd
CY2024Q2	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	-10015000	usd
CY2023Q2	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	288000	usd
	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	-10529000	usd
	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	-2610000	usd
CY2024Q2	us-gaap	Share Based Compensation ShareBasedCompensation	17190000	usd
CY2023Q2	us-gaap	Share Based Compensation ShareBasedCompensation	13563000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	28611000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	26162000	usd
CY2024Q2	us-gaap	Share Based Compensation ShareBasedCompensation	17190000	usd
CY2023Q2	us-gaap	Share Based Compensation ShareBasedCompensation	13563000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	28611000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	26162000	usd
CY2024Q1	us-gaap	Payments For Proceeds From Tenant Allowance PaymentsForProceedsFromTenantAllowance	700000	usd
CY2024Q2	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	400000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	2792000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	8022000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	9238000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	9560000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	9076000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	9331000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	57104000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	105123000	usd
CY2024Q2	xncr	Lessee Operating Lease Liability Tenant Allowance LesseeOperatingLeaseLiabilityTenantAllowance	3252000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	33453000	usd
CY2024Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	68418000	usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1262000	usd
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	67156000	usd
CY2024Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	68418000	usd
CY2024Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	1881000	usd
CY2023Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	2020000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	3762000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	4200000	usd
CY2024Q2	us-gaap	Variable Lease Cost VariableLeaseCost	310000	usd
CY2023Q2	us-gaap	Variable Lease Cost VariableLeaseCost	219000	usd
	us-gaap	Variable Lease Cost VariableLeaseCost	1140000	usd
	us-gaap	Variable Lease Cost VariableLeaseCost	453000	usd
CY2024Q2	us-gaap	Lease Cost LeaseCost	2191000	usd
CY2023Q2	us-gaap	Lease Cost LeaseCost	2239000	usd
	us-gaap	Lease Cost LeaseCost	4902000	usd
	us-gaap	Lease Cost LeaseCost	4653000	usd
CY2024Q2	us-gaap	Operating Lease Payments OperatingLeasePayments	807000	usd
CY2023Q2	us-gaap	Operating Lease Payments OperatingLeasePayments	721000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	1877000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	1445000	usd
CY2024Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P10Y8M12D
CY2024Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.070
CY2023Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P11Y8M12D
CY2023Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.089
CY2024Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	17000000.0	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	45500000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	29800000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	64500000	usd
CY2024Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	17000000.0	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	45500000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	29800000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	64500000	usd
CY2024Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	0	usd
CY2023Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	7900000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	100000	usd
CY2024Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	100000	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023Q4	xncr	Royalty Liability Noncurrent RoyaltyLiabilityNoncurrent	20974000	usd
	xncr	Royalty Liability Owed RoyaltyLiabilityOwed	834000	usd
	xncr	Royalty Liability Payments RoyaltyLiabilityPayments	4448000	usd
	xncr	Royalty Liability Interest Expense Including Amortization Of Closing Costs RoyaltyLiabilityInterestExpenseIncludingAmortizationOfClosingCosts	1900000	usd
CY2024Q2	xncr	Royalty Liability Noncurrent RoyaltyLiabilityNoncurrent	19260000	usd
CY2024Q2	xncr	Royalty Liabilities Short Term Debt RoyaltyLiabilitiesShortTermDebt	6947000	usd
CY2024Q2	xncr	Royalty Liabilities Long Term Debt RoyaltyLiabilitiesLongTermDebt	12313000	usd
CY2024Q2	xncr	Royalty Liability Debt Long Term And Short Term Combined Amount RoyaltyLiabilityDebtLongTermAndShortTermCombinedAmount	19260000	usd
CY2024Q2	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0001326732-24-000043-index-headers.html	Edgar Link	pending
0001326732-24-000043-index.html	Edgar Link	pending
0001326732-24-000043.txt	Edgar Link	pending
0001326732-24-000043-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
xncr-20240630_def.xml	Edgar Link	unprocessable
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
xncr-20240630.htm	Edgar Link	pending
xncr-20240630.xsd	Edgar Link	pending
xncr-20240630xexx101.htm	Edgar Link	pending
xncr-20240630xexx102.htm	Edgar Link	pending
xncr-20240630xexx311.htm	Edgar Link	pending
xncr-20240630xexx312.htm	Edgar Link	pending
xncr-20240630xexx321.htm	Edgar Link	pending
xncr-20240630_cal.xml	Edgar Link	unprocessable
xncr-20240630_lab.xml	Edgar Link	unprocessable
xncr-20240630_pre.xml	Edgar Link	unprocessable
xncr-20240630_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$XNCR
Xencor Inc Stock $xncr

2024 Q3 Form 10-Q Financial Statement

#000132673224000043 Filed on August 05, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$XNCR Xencor Inc Stock $xncr

2024 Q3 Form 10-Q Financial Statement

#000132673224000043 Filed on August 05, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$XNCR
Xencor Inc Stock $xncr